Satellos Bioscience MSLE Balance Sheet (2023-2026)

NASDAQ MSLE
$8.60 -0.21 (-2.38%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Satellos Bioscience Quarterly Balance Sheet

Periods 7 quarters
Latest Jun 2026

Satellos Bioscience reported total assets of $65.77M and total liabilities of $5.86M for the quarter ended Jun 2026. This balance sheet covers 7 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2023 Dec2024 Mar2025 Jun2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 16.21M41.28M18.70M7.39M
Receivables - NetNet Receivables 0.45M0.37M0.73M0.78M
Receivables - OtherOther Receivables 0.10M0.25M-0.36M-0.41M
Receivables 0.45M0.37M0.37M0.37M
Prepaid Assets 1.81M3.80M4.58M3.14M
Current Assets 29.62M52.27M31.88M75.22M65.76M
Non-Current Assets
Property, Plant & Equipment (Net) 0.01M0.00M0.01M
Other Non-Current Assets 0.00M
Non-Current Assets 2.92M0.00M0.01M0.01M0.01M
Assets 32.54M52.27M31.89M75.23M65.77M
Liabilities
Current Liabilities
Accounts Payables 2.66M3.69M4.11M4.56M5.86M
Payables 2.66M3.69M4.11M4.56M5.86M
Accumulated Expenses 2.26M4.16M
Other Accumulated Expenses 14.03M
Current Taxes 3.69M0.07M0.03M
Total Current Liabilities 2.66M3.69M4.11M4.56M5.86M
Non-Current Liabilities
Total Liabilities 2.66M3.69M4.11M4.56M5.86M
Shareholder's Equity
Common Equity 29.88M48.58M27.78M70.66M59.91M
Liabilities and Shareholders Equity 32.54M52.27M31.89M75.23M65.77M
Retained Earnings -34.89M-54.12M81.97M-91.74M-103.46M

Satellos Bioscience Balance Sheet API

Pull Satellos Bioscience's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MSLE&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY